Related Experiment Video
Updated: Jul 18, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion
G K Leung1, M M Véniant, S K Kim
1Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, California 94141-9100, USA.
Abstract:
Microsomal triglyceride transfer protein (MTP) transfers lipids to apolipoprotein B (apoB) within the endoplasmic reticulum, a process that involves direct interactions between apoB and the large subunit of MTP. Recent studies with heterozygous MTP knockout mice have suggested that half-normal levels of MTP in the liver reduce apoB secretion. We hypothesized that reduced apoB secretion in the setting of half-normal MTP levels might be caused by a reduced MTP:apoB ratio in the endoplasmic reticulum, which would reduce the number of apoB-MTP interactions. If this hypothesis were true, half-normal levels of MTP might have little impact on lipoprotein secretion in the setting of half-normal levels of apoB synthesis (since the ratio of MTP to apoB would not be abnormally low) and might cause an exaggerated reduction in lipoprotein secretion in the setting of apoB overexpression (since the MTP:apoB ratio would be even lower). To test this hypothesis, we examined the effects of heterozygous MTP deficiency on apoB metabolism in the setting of normal levels of apoB synthesis, half-normal levels of apoB synthesis (heterozygous Apob deficiency), and increased levels of apoB synthesis (transgenic overexpression of human apoB). Contrary to our expectations, half-normal levels of MTP reduced the plasma apoB100 levels to the same extent ( approximately 25-35%) at each level of apoB synthesis. In addition, apoB secretion from primary hepatocytes was reduced to a comparable extent at each level of apoB synthesis. Thus, these results indicate that the concentration of MTP within the endoplasmic reticulum rather than the MTP:apoB ratio is the critical determinant of lipoprotein secretion. Finally, we found that heterozygosity for an apoB knockout mutation lowered plasma apoB100 levels more than heterozygosity for an MTP knockout allele. Consistent with that result, hepatic triglyceride accumulation was greater in heterozygous apoB knockout mice than in heterozygous MTP knockout mice.
Insights
Reduced microsomal triglyceride transfer protein (MTP) levels impact apolipoprotein B (apoB) secretion by concentration, not MTP:apoB ratio. This finding is crucial for understanding lipoprotein metabolism and related diseases.
Area of Science:
- Lipid Metabolism
- Molecular Biology
- Genetics
Background:
- Microsomal triglyceride transfer protein (MTP) facilitates lipid transfer to apolipoprotein B (apoB) in the endoplasmic reticulum.
- Previous studies suggested heterozygous MTP deficiency reduces apoB secretion, potentially due to an altered MTP:apoB ratio.
Purpose of the Study:
- To investigate whether reduced apoB secretion in heterozygous MTP deficiency is caused by a lower MTP:apoB ratio.
- To determine the critical determinant of lipoprotein secretion: MTP concentration or the MTP:apoB ratio.
Main Methods:
- Examined apoB metabolism in heterozygous MTP knockout mice with normal, half-normal, and overexpressed apoB synthesis.
- Assessed apoB secretion from primary hepatocytes under varying MTP and apoB levels.
Main Results:
- Half-normal MTP levels consistently reduced plasma apoB100 levels by 25-35% across all apoB synthesis levels.
- Hepatic apoB secretion was comparably reduced in primary hepatocytes regardless of apoB synthesis rate.
- Heterozygous apoB deficiency resulted in greater plasma apoB100 reduction and hepatic triglyceride accumulation than heterozygous MTP deficiency.
Conclusions:
- The concentration of MTP in the endoplasmic reticulum, not the MTP:apoB ratio, is the critical factor for lipoprotein secretion.
- MTP levels play a more significant role in regulating apoB levels than previously thought, independent of apoB synthesis rates.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Lipid Catabolism

